An Australian cardiovascular risk equation for type 2 diabetes: The Fremantle diabetes study

Internal Medicine Journal

Volumn 40, Issue 4, 2010, Pages 286-292

  Davis, W A ^a   Knuiman, M W ^b   Davis, T M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Australia; Cardiovascular disease; Ethnic group; Risk assessment; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES EDUCATION; DISEASE DURATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 77951119847     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01958.x     Document Type: Article

References (26)

1. Davis WA, Colagiuri S, Davis TME. Comparison of the Framingham and United Kingdom Prospective Diabetes Study 5-year cardiovascular risk equations in Australian patients with type 2 Diabetes: the Fremantle Diabetes Study. Med J Aust 2009 190 : 180 184.
2. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 : 1837 1847.
3. Stevens RJ, Kothari V, Adler AI, Stratton IM United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 2001 101 : 671 679.
4. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study Risk Engine. Stroke 2002 33 : 1776 1781.
5. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes Care 2007 30 (Suppl 1 S4 41.
6. Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 2000 17 : 667 674.
7. Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2006 49 : 2634 2641.
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
9. Elgrishi I, Ducimetiere P, Richard JL. Reproducibility of analysis of the electrocardiogram in epidemiology using the Minnesota code. Br J Prevent Soc Med 1970 24 : 197 200.
10. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust NZ J Public Health 1999 23 : 453 459.
11. UK Prospective Diabetes Study Group. VIII. Study design, progress and performance. Diabetologia 1991 34 : 877 890.
12. Knuiman MW, Vu HT. Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 1997 51 : 515 519.
13. Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine in patients with newly diagnosed type 2 diabetes. Diabet Med 2005 22 : 554 562.
14. Donnan PT, Donnelly L, New JP, Morris AD. Derivation and validation of a prediction score for major coronary heart disease events in a UK type 2 diabetic population. Diabetes Care 2006 29 : 1231 1236.
15. General Register Office for Scotland. Strategy for a Scotland with an Ageing Population. Policy briefing paper on demography [article online; cited 2007 Jul 26]. Available from: URL: http://www.infoscotland.com/experience/files/ GROS-demography-paper.pdf
16. Australian Institute of Health and Welfare. Australian Trends in Life Expectancy article online; cited 2009 April]. Available from: URL: http://www.aihw.gov.au/mortality/trends.cfm
17. Daniel M, Rowley KG, McDermott R, Mylvaganam A, O'Dea K Diabetes incidence in an Australian Aboriginal population. Diabetes Care 1999 22 : 1993 1998.
18. Welborn TA, Knuiman M, Bartholomew HC, Whittall DE. 1989-90 National Health Survey: prevalence of self-reported diabetes in Australia. Med J Aust 1995 163 : 129 132.
19. Kouris-Blazos A. Morbidity mortality paradox of 1st generation Greek Australians. Asia Pac J Clin Nutr 2002 11 : S569 75.
20. Smith RM, Spargo RM, Hunter EM, King RA, Correll RL, Craig IH et al. Prevalence of hypertension in Kimberley Aborigines and its relationship to ischaemic heart disease. An age-stratified random survey. Med J Aust 1992 156 : 557 562.
21. Keneally T, Elley CR, Robinson E, Bramley D, Drury PL, Kerse NM et al. An association between ethnicity and cardiovascular outcomes for people with type 2 diabetes in New Zealand. Diabet Med 2008 25 : 1302 1308.
22. Sorensen KH, Hilden T. Increased total mortality and decreased functional capacity are associated with low systolic blood pressure among elderly women. Scand J Prim Health Care 1988 6 : 105 110.
23. Rosenson RS. Low HDL-C: a secondary target of dyslipidemia therapy. Am J Med 2005 118 : 1067 1077.
24. Ravera M, Re M, Weiss U, Deferrari L, Deferrari G. Emerging therapeutic strategies in diabetic nephropathy. J Nephrol 2007 20 (Suppl 12 S23 32.
25. Gerstein HC, Miller ME, Byington RP, Goff DC Jr., Bigger JT, Buse JB et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 358 : 2545 2559.
26. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M et al., ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 358 : 2560 2572.